A Cryptic CBFB Deletion–Inversion Expands the Mutational Spectrum of Variants Associated With Cleidocranial Dysplasia
Clinical Genetics · 2025
DOI: 10.1111/cge.14709 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Genetics, 2025. Verfasst von Alistair T Pagnamenta und 6 weiteren Autor:innen. Beteiligte Einrichtung: Oxford BRC, Centre for Human Genetics, University of Oxford, Oxford, UK. Hauptthemen laut MEDLINE: Cleidocranial Dysplasia, Core Binding Factor beta Subunit, Sequence Deletion, Mutation. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 15 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIHR Oxford Biomedical Research Centre, Medical Research Council.
Abstract (Originalsprache)
CBFB encodes the core‐binding factor β subunit, a small protein which heterodimerises with RUNX1‐3 and activates transcription of genes important in bone development. Recently, five families with cleidocranial dysplasia (CCD) were identified harbouring presumed loss of function variants in CBFB . Prompted by a multidisciplinary team review of an affected mother and daughter from the 100 000 Genomes Project with genetically unsolved CCD, we inspected read alignments and identified a deletion–inversion–deletion that removes the first two exons of CBFB . This cryptic variant comprised interlinked deletions of 1310 bp and 1935 bp and had remained undetected by both array‐CGH and the Canvas algorithm. The rearrangement was likely mediated by a palindromic AluSx repeat < 1 kb from the transcriptional start site. Due to high GC content and repeats, reduced read depth is observed at one of the breakpoints. Although the clinical presentation of CBFB ‐related CCD appears to be very similar to RUNX2 ‐related CCD, our patients were of normal stature. The mild developmental delay observed in previously reported cases of CBFB ‐related CCD was not observed. In conclusion, our data strengthens the evidence linking aberrations of the core‐binding factor complex to CCD and extends the mutational spectrum of pathogenic variants.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Oxford BRC, Centre for Human Genetics, University of Oxford, Oxford, UK.
- Department of Clinical Genetics, University Hospitals Bristol NHS Foundation Trust, Bristol, UK.
- Division of Clinical Medicine, The University of Sheffield, Sheffield, UK.
ORCID-Profile: Alistair T Pagnamenta, Mona Hashim, Amaka C Offiah, Jenny C Taylor, Sarah F Smithson
Förderung
- NIHR Oxford Biomedical Research Centre
- Medical Research Council
Zitieren
APA
Pagnamenta, A. T., Hashim, M., Kennedy, J., Lawton, B., Offiah, A. C., Taylor, J. C., & Smithson, S. F. (2025). A Cryptic CBFB Deletion–Inversion Expands the Mutational Spectrum of Variants Associated With Cleidocranial Dysplasia. Clinical Genetics. https://doi.org/10.1111/cge.14709
Vancouver
Pagnamenta AT, Hashim M, Kennedy J, Lawton B, Offiah AC, Taylor JC, et al. A Cryptic CBFB Deletion–Inversion Expands the Mutational Spectrum of Variants Associated With Cleidocranial Dysplasia. Clinical Genetics. 2025. doi:10.1111/cge.14709
BibTeX
@article{Pagnamenta2025,
author = {Pagnamenta, Alistair T and Hashim, Mona and Kennedy, Joanna and Lawton, Beth and Offiah, Amaka C and Taylor, Jenny C and Smithson, Sarah F},
title = {A Cryptic CBFB Deletion–Inversion Expands the Mutational Spectrum of Variants Associated With Cleidocranial Dysplasia},
journal = {Clinical Genetics},
year = {2025},
doi = {10.1111/cge.14709}
}
EUVIMED